ECO Animal Health Group plc (AIM:EAH)
London · Delayed Price · Currency is GBP · Price in GBX 79.20
+1.70 (2.19%)
Jul 30, 2025, 9:31 AM GMT+1
ECO Animal Health Group Revenue
In the fiscal year ending March 31, 2025, ECO Animal Health Group had annual revenue of 79.60M GBP, down -10.99%. ECO Animal Health Group had revenue of 46.41M in the half year ending March 31, 2025, a decrease of -8.00%.
Revenue
79.60M
Revenue Growth
-10.99%
P/S Ratio
0.66
Revenue / Employee
355.34K
Employees
224
Market Cap
52.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 79.60M | -9.83M | -10.99% |
| Mar 31, 2024 | 89.42M | 4.11M | 4.82% |
| Mar 31, 2023 | 85.31M | 3.12M | 3.79% |
| Mar 31, 2022 | 82.20M | -23.41M | -22.17% |
| Mar 31, 2021 | 105.61M | 33.50M | 46.46% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.72B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
ECO Animal Health Group News
- 14 days ago - AIM Market Roundup: Oxford Biodynamics, GCM Resources, ECO Animal Health - The Armchair Trader